MedPath

The effect of Phoenix Dactylifera Spathe vaginal gel on sexual function and Vaginal Atrophy in Menopausal wome

Phase 3
Not yet recruiting
Conditions
Sexual function in menopause
Vaginal atrophy in menopause.
Menopausal and other perimenopausal disorders
Registration Number
IRCT20210517051331N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
110
Inclusion Criteria

Being married
Be literate
No medical condition of the woman or her husband (according to Ms. Menopause)
Age range under 65 years
More than a year has passed since the last menstrual period
Having sex for the past month
Have sex at least once a month
Existence of symptoms of vaginal atrophy
Sexual function score less than 26/55

Exclusion Criteria

Any physical or motor disability
Training on sexual issues in the last 4 weeks
Use of psychiatric drugs, Fluoxetine, Vitamin E, Propranolol and other chemical or herbal medicines that affect menopausal symptoms
Smoking and alcohol or drug use

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath